Skip to product information
1 of 1

Cloud-clone

SKU:PAC285Mu01

Polyclonal Antibody to Anterior Gradient 2 (AGR2)

Polyclonal Antibody to Anterior Gradient 2 (AGR2)

Regular price $360.00 USD
Regular price Sale price $360.00 USD
Sale Sold out
Shipping calculated at checkout.
UOM
Concentration
Organism species

Western blotting: 0.2-2µg/mL;1:250-2500
Immunohistochemistry: 5-20µg/mL;1:25-100
Immunocytochemistry: 5-20µg/mL;1:25-100
Optimal working dilutions must be determined by end user.

Product No.

PAC285Mu01

Organism Species

Mus musculus (Mouse).

Source

Polyclonal antibody preparation

Host

Rabbit

Potency

n/a

Ig Type

IgG

Purification

Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Label

None

Immunogen

RPC285Mu01-Recombinant Anterior Gradient 2 (AGR2)

Buffer Formulation

PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

Traits

Liquid

Concentration

500µg/mL

Organism Species More

Homo sapiens (Human), Rattus norvegicus (Rat)

Applications

WB; IHC; ICC; IP.

If the antibody is used in flow cytometry, please check FCM antibodies.

UOM

20µl 100µl 200µl 1ml 10ml

SPECIFITY

The antibody is a rabbit polyclonal antibody raised against AGR2. It has been selected for its ability to recognize AGR2 in immunohistochemical staining and western blotting.

USAGE

Western blotting: 0.2-2µg/mL;1:250-2500
Immunohistochemistry: 5-20µg/mL;1:25-100
Immunocytochemistry: 5-20µg/mL;1:25-100
Optimal working dilutions must be determined by end user.

STORAGE

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Magazine

Citations

Cancer Biomarkers

Serum AGR2 as an early diagnostic and postoperative prognostic biomarker of human lung adenocarcinoma MetaPress: n7137r6271u54118

Molecular & Cellular Proteomics

Integrated Proteomic Profiling of Cell Line Conditioned Media and Pancreatic Juice for the Identification of Pancreatic Cancer Biomarkers PubMed: PMC3205865

Prostate.

Anterior gradient 2 (AGR2): blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype Pubmed: 22911164

BMC Cancer.

Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9 Pubmed: 24007603

Clinical Cancer Research

Validation of Biomarkers That Complement CA19.9 in Detecting Early Pancreatic Cancer Pubmed:25239611

PLoS One

AGR3 in Breast Cancer: Prognostic Impact and Suitable Serum-Based Biomarker for Early Cancer Detection PubMed: 25875093

Clinical Neurology and Neurosurgery

Serum AGR2 as a useful biomarker for pituitary adenomas S0303846717300045

Oncotarget

Identification, characterization and application of a new peptide against anterior gradient homolog 2 (AGR2) Pubmed:29937991

Int J Oncol

Anterior gradient protein 2 is a marker of tumor aggressiveness in breast cancer and favors chemotherapy‑induced senescence escape 34913074

International Journal of Cancer

Proteome profiling of enzalutamide‐resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration‐resistant prostate cancer Pubmed:35689436


Catalog No.

Related products for research use of Mus musculus (Mouse) Organism species

Applications (RESEARCH USE ONLY!)

RPC285Mu01

Recombinant Anterior Gradient 2 (AGR2)

Positive Control; Immunogen; SDS-PAGE; WB.

PAC285Mu01

Polyclonal Antibody to Anterior Gradient 2 (AGR2)

WB; IHC; ICC; IP.

LAC285Mu71

Biotin-Linked Polyclonal Antibody to Anterior Gradient 2 (AGR2)

WB; IHC; ICC.

KSC285Mu01

ELISA Kit DIY Materials for Anterior Gradient 2 (AGR2)

Main materials for "Do It(ELISA Kit) Yourself"

 

View full details